Anavex Life Sciences Corp (AVXL)

[sokol]

Yes, Anavex alluded to Illumina and its sequencing technology on Feburary 7. Saying this in part:

”The company has completed both RNA and whole exome DNA genome sequencing from ANAVEX®2-73-treated patients utilizing Illumina HiSeq 2500 Next Generation Sequencing (NGS) technology. The analysis of this data has characterized several genomic alterations in well-characterized targets that have the potential to be used as biomarkers, which the Company plans to use to identify optimal patients in forthcoming clinical trials. This novel, precision-medicine approach will enable enriched clinical trial populations, more robust regulatory submissions and better characterized clinical trial designs.”

See this from Febuary 7: Anavex Life Sciences Provides Clinical Programs Update and Reports Fiscal First Quarter 2018 Financial Results. http://anavex.com/anavex-life-sciences-provides-clinical-programs-update-reports-fiscal-first-quarter-2018-financial-results/

Of course, the significance did not hit home until Bio hit me/us in the face with the great post today. We all owe Bio a great debt of gratitude.